
About Us

Geoffrey Feld, Ph.D.
Founder, Principal Consultant
Ph.D. in Biophysical Chemistry from the University of California, Berkeley
B.S. in Chemistry from Georgia Tech (minor, International Affairs)
Technical Expertise: Structural biology, host-microbe relationships, microbiome, human & animal nutrition, metabolomics, proteomics, multiomics, lab automation, cell & gene therapy discovery and manufacturing
Additional interests: Animal welfare, creative writing, The Great Outdoors

Will Lawrence, Ph.D.
Ecosystem Contract Writer
Ph.D. in Biomedical Sciences from The Ohio State University
Technical Expertise: Neuroscience, cell biology, spatial biology, specimen procurement

Tom Fare, Ph.D.
Ecosystem Contract Writer
Ph.D. in Electrical Engineering & Sciences from the University of Pennsylvania
Tom is an accomplished scientist and communicator with over 30 years of experience in the biotechnology industry, most recently as Senior Editor at the Journal of Precision Medicine. Tom is excited to help clients discover and convey the value of their biomarker studies supporting precision medicine initiatives.

Waylon Hastings, Ph.D.
Ecosystem Contract Writer
Ph.D. in Biobehavioral Health & Bioethics from Pennsylvania State University
M.S. in Educational Administration, B.S. in Biochemistry & Genetics (minor, Chemistry), B.A. in Mathematics (minor, Classics) from Texas A&M University
Assistant Professor of Nutrition, Texas A&M University
Molecular epidemiology, human biospecimen collection and processing, measurement reliability and reproducibility, commercialization and clinical translation of biological aging estimates
Waylon is citizen scientist with over a decade of bench experience processing biospecimens (culture, blood, urine, saliva) for a variety of downstream applications (e.g., immunoassay, qPCR, RNAseq). Partnering with diverse entities spanning pharma (Bayer HealthCare), industry (Chronomics), and intramural/extramural consortia (Telomere Research Network; Consortium of Metabolomics Studies; CALERIE™), he works to develop, validate, and disseminate multi-dimensional methods to measures human aging and functional decline.

Ludger Goeminne, Ph.D.
Ecosystem Contract Writer
Postdoctoral Researcher at Brigham and Women's Hospital – Harvard Medical School
B.S. and M.S. in Bioscience Engineering: Cell and gene biotechnology, Ghent University, Belgium
Dr. Ludger Goeminne is a postdoctoral researcher in the Gladyshev Lab at Brigham and Women’s Hospital and Harvard Medical School who is interested in the proteomics of aging. As a member of the Biomarkers of Aging Consortium, he helped identify barriers hindering the clinical translation of biomarkers of aging and developed actionable guidance for overcoming them.
He developed patented organ-specific aging models leveraging blood proteomics data from over 53,000 UK Biobank participants and showed that chronic diseases can manifest as accelerated aging of specific systems, advocating for personalized anti-aging strategies targeting the oldest organs alongside systemic aging.
Dr. Goeminne is the core developer of MSqRob, a robust and versatile R package for differential abundance quantification in mass spectrometry-based proteomics.